Stock Exchange:
Copenhague
Sector:
Health
Sub-sector:
Specialised production
Turnover last year:
232.261 MDKK 2023
Profits last year:
83.683 MDKK 2023
Activity: Treatments and technologies for health.
NOVO NORDISK is a global healthcare company focused on the treatment of diabetes and other serious chronic diseases such as obesity and rare blood diseases and rare endocrine diseases.
http://www.novonordisk.com